Uterine Cervical Neoplasms

Oncology
3
Pipeline Programs
4
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
Bintrafusp alfaPhase 21 trial
Active Trials
NCT04246489Completed146Est. Dec 2022
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
1
Increased use of IC/IS technique in BTPhase 21 trial
Active Trials
NCT03617133Recruiting1,000Est. Apr 2031
Bristol Myers Squibb
1 program
1
Nivolumab 40 mg in 4 ml InjectionPhase 21 trial
Active Trials
NCT05492123Recruiting112Est. Mar 2028
Precision BioSciences
1 program
detect HPV E7 ctDNAN/A1 trial
Active Trials
NCT05531981Unknown350Est. Sep 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Bristol Myers SquibbNivolumab 40 mg in 4 ml Injection
Merck & Co.Bintrafusp alfa
Heidelberg PharmaIncreased use of IC/IS technique in BT
Precision BioSciencesdetect HPV E7 ctDNA

Clinical Trials (4)

Total enrollment: 1,608 patients across 4 trials

NCT05492123Bristol Myers SquibbNivolumab 40 mg in 4 ml Injection

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Start: Aug 2022Est. completion: Mar 2028112 patients
Phase 2Recruiting
NCT04246489Merck & Co.Bintrafusp alfa

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

Start: Mar 2020Est. completion: Dec 2022146 patients
Phase 2Completed
NCT03617133Heidelberg PharmaIncreased use of IC/IS technique in BT

Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

Start: Apr 2016Est. completion: Apr 20311,000 patients
Phase 2Recruiting

Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer

Start: Sep 2022Est. completion: Sep 2025350 patients
N/AUnknown

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 1,608 patients
4 companies competing in this space